BRAF and glioblastoma: Although less common, the MAPK MEK-ERK1/2 pathway has been implicated in increased cell survival, migration, and invasion in glioblastoma, with direct upstream mutations in the MAPK pathway having been identified, namely in RAS and BRAF [101].